Multicenter study of levodopa carbidopa intestinal gel in Parkinson’s disease: the Turkish experience

BACKGROUND/AIM: Our purpose was to determine the efficacy of levodopa carbidopa intestinal gel (LCIG) in a series of Turkish patients with Parkinson’s disease (PD). MATERIALS AND METHODS: We had telephone calls with 54 patients from 11 neurology centers who were on LCIG treatment, and 44 patients or...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Turk J Med Sci
Autors principals: GÜLTEKİN, Murat, ULUKAN, Çağrı, TEZCAN, Sabiha, DOĞU, Okan, HANAĞASI, Haşmet, BİLGİÇ, Başar, BORA TOKÇAER, Ayşe, ÇAKMUR, Raif, ELİBOL, Bülent, MİRZA, Meral, İNCE GÜNAL, Dilek, ERER ÖZBEK, Çiğdem Sevda, KENANGİL, Gülay, YILMAZ KÜSBECİ, Özge, AKBOSTANCI, Muhittin Cenk
Format: Artigo
Idioma:Inglês
Publicat: The Scientific and Technological Research Council of Turkey 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080356/
https://ncbi.nlm.nih.gov/pubmed/31731332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-1904-150
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars